Global and Regional Biochips

Biochips Comprehensive Study by Type (DNA Chips, Protein Chips, Lab-on-a-Chip, Others), Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, Others), End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, Others) Players and Region - Global Market Outlook to 2026

Biochips Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Biochips Market Scope?
Upsurge in spending on the clinical research will help to boost global biochips market all over the world. Biochip can be considered as a micro-reactor. It can detect a particular analytic like an enzyme, protein, DNA, biological molecule or antibody. The key function of biochip is execute hundreds of biological reactions in a few seconds like decoding genes. The applications of biochip includes trace a person or animal anywhere in the world, store and update the info of a person like medical financial as well as demographics.

The Biochips market study is being classified by Type (DNA Chips, Protein Chips, Lab-on-a-Chip and Others), by Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Others) and major geographies with country level break-up.

Research Analyst at AMA predicts that Players from United States and German will contribute to the maximum growth of Global Biochips market throughout the predicted period.

Abbott Laboratories (United States), Agilent Technologies Inc. (United States), Perkinelmer Inc. (United States), Fluidigm Corporation (United States), Illumina Inc. (United States), GE Healthcare (United States), Bio-Rad Laboratories Inc. (United States), Cepheid Inc. (United States), Thermo Fisher Scientific Inc. (United States) and Roche Diagnostics AG (Switzerland) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Greiner Bio-One GmbH (Germany), Zerzog GmbH & Co. KG Kunststofftechnik Recycling (Germany), Otto Michael GmbH & Co. KG (Germany) and Astra Bitech GmbH (Germany).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Biochips market by Type, Application and Region.

On the basis of geography, the market of Biochips has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2020. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement.

Market Influencers and their development strategies
On 4 January 2017, Abbott has announced an acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical device arena. The transaction provides Abbott with expanded opportunities for future growth and is an important part of the company's ongoing effort to develop a strong, diverse portfolio of devices, diagnostics, nutritionals and branded generic pharmaceuticals.
On 14th March 2019, Abbott has expanded indication to its leading MitraClip device used to repair a leaky mitral valve without open-heart surgery. Supported by the results of the landmark COAPT Trial, MitraClip is the first trans catheter mitral valve intervention therapy approved by FDA to treat select heart failure patients with clinically significant secondary, or functional, mitral regurgitation (MR).


Influencing Market Trend
  • Growing Demand for Personalized Medications
  • Emerging in Number of Biochip Application

Market Drivers
  • Growing Expenditure of Clinical Research
  • Fueling Patient Awareness about Biochips
  • Upsurging Demand due to Increasing Diagnostic Methods as we as low Cost through Technical Advancement

Opportunities
  • Huge Demand in Academic and Research Institutes
  • Growing Demand in Untapped Market in Developing Nations

Restraints
  • Higher Initial Investments in Manufacturing Smart Biochips
  • Irregularities Received In Healthcare Coverage around the Globe

Challenges
  • Lack of Awareness about Biochip Technology
  • Rising Concern about Fabrication of Biochips


Key Target Audience
Medical Research Institutes, Healthcare Industry, Governmental and Research Organizations, Associations and Industry Bodies, Technology Providers and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • DNA Chips
  • Protein Chips
  • Lab-on-a-Chip
  • Others
By Application
  • Drug Discovery & Development
  • Disease Diagnostics
  • Genomics
  • Proteomics
  • Agriculture
  • Others
By End User
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Diagnostics Centers
  • Academic & Research Institutes
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Expenditure of Clinical Research
      • 3.2.2. Fueling Patient Awareness about Biochips
      • 3.2.3. Upsurging Demand due to Increasing Diagnostic Methods as we as low Cost through Technical Advancement
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness about Biochip Technology
      • 3.3.2. Rising Concern about Fabrication of Biochips
    • 3.4. Market Trends
      • 3.4.1. Growing Demand for Personalized Medications
      • 3.4.2. Emerging in Number of Biochip Application
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biochips, by Type, Application, End User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Biochips (Value)
      • 5.2.1. Global Biochips by: Type (Value)
        • 5.2.1.1. DNA Chips
        • 5.2.1.2. Protein Chips
        • 5.2.1.3. Lab-on-a-Chip
        • 5.2.1.4. Others
      • 5.2.2. Global Biochips by: Application (Value)
        • 5.2.2.1. Drug Discovery & Development
        • 5.2.2.2. Disease Diagnostics
        • 5.2.2.3. Genomics
        • 5.2.2.4. Proteomics
        • 5.2.2.5. Agriculture
        • 5.2.2.6. Others
      • 5.2.3. Global Biochips by: End User (Value)
        • 5.2.3.1. Biotechnology & Pharmaceutical Companies
        • 5.2.3.2. Hospitals & Diagnostics Centers
        • 5.2.3.3. Academic & Research Institutes
        • 5.2.3.4. Others
      • 5.2.4. Global Biochips Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Biochips (Volume)
      • 5.3.1. Global Biochips by: Type (Volume)
        • 5.3.1.1. DNA Chips
        • 5.3.1.2. Protein Chips
        • 5.3.1.3. Lab-on-a-Chip
        • 5.3.1.4. Others
      • 5.3.2. Global Biochips by: Application (Volume)
        • 5.3.2.1. Drug Discovery & Development
        • 5.3.2.2. Disease Diagnostics
        • 5.3.2.3. Genomics
        • 5.3.2.4. Proteomics
        • 5.3.2.5. Agriculture
        • 5.3.2.6. Others
      • 5.3.3. Global Biochips by: End User (Volume)
        • 5.3.3.1. Biotechnology & Pharmaceutical Companies
        • 5.3.3.2. Hospitals & Diagnostics Centers
        • 5.3.3.3. Academic & Research Institutes
        • 5.3.3.4. Others
      • 5.3.4. Global Biochips Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Biochips (Price)
      • 5.4.1. Global Biochips by: Type (Price)
  • 6. Biochips: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Agilent Technologies Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Perkinelmer Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Fluidigm Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Illumina Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GE Healthcare (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bio-Rad Laboratories Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cepheid Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Thermo Fisher Scientific Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Roche Diagnostics AG (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Biochips Sale, by Type, Application, End User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Biochips (Value)
      • 7.2.1. Global Biochips by: Type (Value)
        • 7.2.1.1. DNA Chips
        • 7.2.1.2. Protein Chips
        • 7.2.1.3. Lab-on-a-Chip
        • 7.2.1.4. Others
      • 7.2.2. Global Biochips by: Application (Value)
        • 7.2.2.1. Drug Discovery & Development
        • 7.2.2.2. Disease Diagnostics
        • 7.2.2.3. Genomics
        • 7.2.2.4. Proteomics
        • 7.2.2.5. Agriculture
        • 7.2.2.6. Others
      • 7.2.3. Global Biochips by: End User (Value)
        • 7.2.3.1. Biotechnology & Pharmaceutical Companies
        • 7.2.3.2. Hospitals & Diagnostics Centers
        • 7.2.3.3. Academic & Research Institutes
        • 7.2.3.4. Others
      • 7.2.4. Global Biochips Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Biochips (Volume)
      • 7.3.1. Global Biochips by: Type (Volume)
        • 7.3.1.1. DNA Chips
        • 7.3.1.2. Protein Chips
        • 7.3.1.3. Lab-on-a-Chip
        • 7.3.1.4. Others
      • 7.3.2. Global Biochips by: Application (Volume)
        • 7.3.2.1. Drug Discovery & Development
        • 7.3.2.2. Disease Diagnostics
        • 7.3.2.3. Genomics
        • 7.3.2.4. Proteomics
        • 7.3.2.5. Agriculture
        • 7.3.2.6. Others
      • 7.3.3. Global Biochips by: End User (Volume)
        • 7.3.3.1. Biotechnology & Pharmaceutical Companies
        • 7.3.3.2. Hospitals & Diagnostics Centers
        • 7.3.3.3. Academic & Research Institutes
        • 7.3.3.4. Others
      • 7.3.4. Global Biochips Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Biochips (Price)
      • 7.4.1. Global Biochips by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biochips: by Type(USD Million)
  • Table 2. Biochips DNA Chips , by Region USD Million (2015-2020)
  • Table 3. Biochips Protein Chips , by Region USD Million (2015-2020)
  • Table 4. Biochips Lab-on-a-Chip , by Region USD Million (2015-2020)
  • Table 5. Biochips Others , by Region USD Million (2015-2020)
  • Table 6. Biochips: by Application(USD Million)
  • Table 7. Biochips Drug Discovery & Development , by Region USD Million (2015-2020)
  • Table 8. Biochips Disease Diagnostics , by Region USD Million (2015-2020)
  • Table 9. Biochips Genomics , by Region USD Million (2015-2020)
  • Table 10. Biochips Proteomics , by Region USD Million (2015-2020)
  • Table 11. Biochips Agriculture , by Region USD Million (2015-2020)
  • Table 12. Biochips Others , by Region USD Million (2015-2020)
  • Table 13. Biochips: by End User(USD Million)
  • Table 14. Biochips Biotechnology & Pharmaceutical Companies , by Region USD Million (2015-2020)
  • Table 15. Biochips Hospitals & Diagnostics Centers , by Region USD Million (2015-2020)
  • Table 16. Biochips Academic & Research Institutes , by Region USD Million (2015-2020)
  • Table 17. Biochips Others , by Region USD Million (2015-2020)
  • Table 18. South America Biochips, by Country USD Million (2015-2020)
  • Table 19. South America Biochips, by Type USD Million (2015-2020)
  • Table 20. South America Biochips, by Application USD Million (2015-2020)
  • Table 21. South America Biochips, by End User USD Million (2015-2020)
  • Table 22. Brazil Biochips, by Type USD Million (2015-2020)
  • Table 23. Brazil Biochips, by Application USD Million (2015-2020)
  • Table 24. Brazil Biochips, by End User USD Million (2015-2020)
  • Table 25. Argentina Biochips, by Type USD Million (2015-2020)
  • Table 26. Argentina Biochips, by Application USD Million (2015-2020)
  • Table 27. Argentina Biochips, by End User USD Million (2015-2020)
  • Table 28. Rest of South America Biochips, by Type USD Million (2015-2020)
  • Table 29. Rest of South America Biochips, by Application USD Million (2015-2020)
  • Table 30. Rest of South America Biochips, by End User USD Million (2015-2020)
  • Table 31. Asia Pacific Biochips, by Country USD Million (2015-2020)
  • Table 32. Asia Pacific Biochips, by Type USD Million (2015-2020)
  • Table 33. Asia Pacific Biochips, by Application USD Million (2015-2020)
  • Table 34. Asia Pacific Biochips, by End User USD Million (2015-2020)
  • Table 35. China Biochips, by Type USD Million (2015-2020)
  • Table 36. China Biochips, by Application USD Million (2015-2020)
  • Table 37. China Biochips, by End User USD Million (2015-2020)
  • Table 38. Japan Biochips, by Type USD Million (2015-2020)
  • Table 39. Japan Biochips, by Application USD Million (2015-2020)
  • Table 40. Japan Biochips, by End User USD Million (2015-2020)
  • Table 41. India Biochips, by Type USD Million (2015-2020)
  • Table 42. India Biochips, by Application USD Million (2015-2020)
  • Table 43. India Biochips, by End User USD Million (2015-2020)
  • Table 44. South Korea Biochips, by Type USD Million (2015-2020)
  • Table 45. South Korea Biochips, by Application USD Million (2015-2020)
  • Table 46. South Korea Biochips, by End User USD Million (2015-2020)
  • Table 47. Taiwan Biochips, by Type USD Million (2015-2020)
  • Table 48. Taiwan Biochips, by Application USD Million (2015-2020)
  • Table 49. Taiwan Biochips, by End User USD Million (2015-2020)
  • Table 50. Australia Biochips, by Type USD Million (2015-2020)
  • Table 51. Australia Biochips, by Application USD Million (2015-2020)
  • Table 52. Australia Biochips, by End User USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Biochips, by Type USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Biochips, by Application USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Biochips, by End User USD Million (2015-2020)
  • Table 56. Europe Biochips, by Country USD Million (2015-2020)
  • Table 57. Europe Biochips, by Type USD Million (2015-2020)
  • Table 58. Europe Biochips, by Application USD Million (2015-2020)
  • Table 59. Europe Biochips, by End User USD Million (2015-2020)
  • Table 60. Germany Biochips, by Type USD Million (2015-2020)
  • Table 61. Germany Biochips, by Application USD Million (2015-2020)
  • Table 62. Germany Biochips, by End User USD Million (2015-2020)
  • Table 63. France Biochips, by Type USD Million (2015-2020)
  • Table 64. France Biochips, by Application USD Million (2015-2020)
  • Table 65. France Biochips, by End User USD Million (2015-2020)
  • Table 66. Italy Biochips, by Type USD Million (2015-2020)
  • Table 67. Italy Biochips, by Application USD Million (2015-2020)
  • Table 68. Italy Biochips, by End User USD Million (2015-2020)
  • Table 69. United Kingdom Biochips, by Type USD Million (2015-2020)
  • Table 70. United Kingdom Biochips, by Application USD Million (2015-2020)
  • Table 71. United Kingdom Biochips, by End User USD Million (2015-2020)
  • Table 72. Netherlands Biochips, by Type USD Million (2015-2020)
  • Table 73. Netherlands Biochips, by Application USD Million (2015-2020)
  • Table 74. Netherlands Biochips, by End User USD Million (2015-2020)
  • Table 75. Rest of Europe Biochips, by Type USD Million (2015-2020)
  • Table 76. Rest of Europe Biochips, by Application USD Million (2015-2020)
  • Table 77. Rest of Europe Biochips, by End User USD Million (2015-2020)
  • Table 78. MEA Biochips, by Country USD Million (2015-2020)
  • Table 79. MEA Biochips, by Type USD Million (2015-2020)
  • Table 80. MEA Biochips, by Application USD Million (2015-2020)
  • Table 81. MEA Biochips, by End User USD Million (2015-2020)
  • Table 82. Middle East Biochips, by Type USD Million (2015-2020)
  • Table 83. Middle East Biochips, by Application USD Million (2015-2020)
  • Table 84. Middle East Biochips, by End User USD Million (2015-2020)
  • Table 85. Africa Biochips, by Type USD Million (2015-2020)
  • Table 86. Africa Biochips, by Application USD Million (2015-2020)
  • Table 87. Africa Biochips, by End User USD Million (2015-2020)
  • Table 88. North America Biochips, by Country USD Million (2015-2020)
  • Table 89. North America Biochips, by Type USD Million (2015-2020)
  • Table 90. North America Biochips, by Application USD Million (2015-2020)
  • Table 91. North America Biochips, by End User USD Million (2015-2020)
  • Table 92. United States Biochips, by Type USD Million (2015-2020)
  • Table 93. United States Biochips, by Application USD Million (2015-2020)
  • Table 94. United States Biochips, by End User USD Million (2015-2020)
  • Table 95. Canada Biochips, by Type USD Million (2015-2020)
  • Table 96. Canada Biochips, by Application USD Million (2015-2020)
  • Table 97. Canada Biochips, by End User USD Million (2015-2020)
  • Table 98. Mexico Biochips, by Type USD Million (2015-2020)
  • Table 99. Mexico Biochips, by Application USD Million (2015-2020)
  • Table 100. Mexico Biochips, by End User USD Million (2015-2020)
  • Table 101. Biochips Sales: by Type(Million Units)
  • Table 102. Biochips Sales DNA Chips , by Region Million Units (2015-2020)
  • Table 103. Biochips Sales Protein Chips , by Region Million Units (2015-2020)
  • Table 104. Biochips Sales Lab-on-a-Chip , by Region Million Units (2015-2020)
  • Table 105. Biochips Sales Others , by Region Million Units (2015-2020)
  • Table 106. Biochips Sales: by Application(Million Units)
  • Table 107. Biochips Sales Drug Discovery & Development , by Region Million Units (2015-2020)
  • Table 108. Biochips Sales Disease Diagnostics , by Region Million Units (2015-2020)
  • Table 109. Biochips Sales Genomics , by Region Million Units (2015-2020)
  • Table 110. Biochips Sales Proteomics , by Region Million Units (2015-2020)
  • Table 111. Biochips Sales Agriculture , by Region Million Units (2015-2020)
  • Table 112. Biochips Sales Others , by Region Million Units (2015-2020)
  • Table 113. Biochips Sales: by End User(Million Units)
  • Table 114. Biochips Sales Biotechnology & Pharmaceutical Companies , by Region Million Units (2015-2020)
  • Table 115. Biochips Sales Hospitals & Diagnostics Centers , by Region Million Units (2015-2020)
  • Table 116. Biochips Sales Academic & Research Institutes , by Region Million Units (2015-2020)
  • Table 117. Biochips Sales Others , by Region Million Units (2015-2020)
  • Table 118. South America Biochips Sales, by Country Million Units (2015-2020)
  • Table 119. South America Biochips Sales, by Type Million Units (2015-2020)
  • Table 120. South America Biochips Sales, by Application Million Units (2015-2020)
  • Table 121. South America Biochips Sales, by End User Million Units (2015-2020)
  • Table 122. Brazil Biochips Sales, by Type Million Units (2015-2020)
  • Table 123. Brazil Biochips Sales, by Application Million Units (2015-2020)
  • Table 124. Brazil Biochips Sales, by End User Million Units (2015-2020)
  • Table 125. Argentina Biochips Sales, by Type Million Units (2015-2020)
  • Table 126. Argentina Biochips Sales, by Application Million Units (2015-2020)
  • Table 127. Argentina Biochips Sales, by End User Million Units (2015-2020)
  • Table 128. Rest of South America Biochips Sales, by Type Million Units (2015-2020)
  • Table 129. Rest of South America Biochips Sales, by Application Million Units (2015-2020)
  • Table 130. Rest of South America Biochips Sales, by End User Million Units (2015-2020)
  • Table 131. Asia Pacific Biochips Sales, by Country Million Units (2015-2020)
  • Table 132. Asia Pacific Biochips Sales, by Type Million Units (2015-2020)
  • Table 133. Asia Pacific Biochips Sales, by Application Million Units (2015-2020)
  • Table 134. Asia Pacific Biochips Sales, by End User Million Units (2015-2020)
  • Table 135. China Biochips Sales, by Type Million Units (2015-2020)
  • Table 136. China Biochips Sales, by Application Million Units (2015-2020)
  • Table 137. China Biochips Sales, by End User Million Units (2015-2020)
  • Table 138. Japan Biochips Sales, by Type Million Units (2015-2020)
  • Table 139. Japan Biochips Sales, by Application Million Units (2015-2020)
  • Table 140. Japan Biochips Sales, by End User Million Units (2015-2020)
  • Table 141. India Biochips Sales, by Type Million Units (2015-2020)
  • Table 142. India Biochips Sales, by Application Million Units (2015-2020)
  • Table 143. India Biochips Sales, by End User Million Units (2015-2020)
  • Table 144. South Korea Biochips Sales, by Type Million Units (2015-2020)
  • Table 145. South Korea Biochips Sales, by Application Million Units (2015-2020)
  • Table 146. South Korea Biochips Sales, by End User Million Units (2015-2020)
  • Table 147. Taiwan Biochips Sales, by Type Million Units (2015-2020)
  • Table 148. Taiwan Biochips Sales, by Application Million Units (2015-2020)
  • Table 149. Taiwan Biochips Sales, by End User Million Units (2015-2020)
  • Table 150. Australia Biochips Sales, by Type Million Units (2015-2020)
  • Table 151. Australia Biochips Sales, by Application Million Units (2015-2020)
  • Table 152. Australia Biochips Sales, by End User Million Units (2015-2020)
  • Table 153. Rest of Asia-Pacific Biochips Sales, by Type Million Units (2015-2020)
  • Table 154. Rest of Asia-Pacific Biochips Sales, by Application Million Units (2015-2020)
  • Table 155. Rest of Asia-Pacific Biochips Sales, by End User Million Units (2015-2020)
  • Table 156. Europe Biochips Sales, by Country Million Units (2015-2020)
  • Table 157. Europe Biochips Sales, by Type Million Units (2015-2020)
  • Table 158. Europe Biochips Sales, by Application Million Units (2015-2020)
  • Table 159. Europe Biochips Sales, by End User Million Units (2015-2020)
  • Table 160. Germany Biochips Sales, by Type Million Units (2015-2020)
  • Table 161. Germany Biochips Sales, by Application Million Units (2015-2020)
  • Table 162. Germany Biochips Sales, by End User Million Units (2015-2020)
  • Table 163. France Biochips Sales, by Type Million Units (2015-2020)
  • Table 164. France Biochips Sales, by Application Million Units (2015-2020)
  • Table 165. France Biochips Sales, by End User Million Units (2015-2020)
  • Table 166. Italy Biochips Sales, by Type Million Units (2015-2020)
  • Table 167. Italy Biochips Sales, by Application Million Units (2015-2020)
  • Table 168. Italy Biochips Sales, by End User Million Units (2015-2020)
  • Table 169. United Kingdom Biochips Sales, by Type Million Units (2015-2020)
  • Table 170. United Kingdom Biochips Sales, by Application Million Units (2015-2020)
  • Table 171. United Kingdom Biochips Sales, by End User Million Units (2015-2020)
  • Table 172. Netherlands Biochips Sales, by Type Million Units (2015-2020)
  • Table 173. Netherlands Biochips Sales, by Application Million Units (2015-2020)
  • Table 174. Netherlands Biochips Sales, by End User Million Units (2015-2020)
  • Table 175. Rest of Europe Biochips Sales, by Type Million Units (2015-2020)
  • Table 176. Rest of Europe Biochips Sales, by Application Million Units (2015-2020)
  • Table 177. Rest of Europe Biochips Sales, by End User Million Units (2015-2020)
  • Table 178. MEA Biochips Sales, by Country Million Units (2015-2020)
  • Table 179. MEA Biochips Sales, by Type Million Units (2015-2020)
  • Table 180. MEA Biochips Sales, by Application Million Units (2015-2020)
  • Table 181. MEA Biochips Sales, by End User Million Units (2015-2020)
  • Table 182. Middle East Biochips Sales, by Type Million Units (2015-2020)
  • Table 183. Middle East Biochips Sales, by Application Million Units (2015-2020)
  • Table 184. Middle East Biochips Sales, by End User Million Units (2015-2020)
  • Table 185. Africa Biochips Sales, by Type Million Units (2015-2020)
  • Table 186. Africa Biochips Sales, by Application Million Units (2015-2020)
  • Table 187. Africa Biochips Sales, by End User Million Units (2015-2020)
  • Table 188. North America Biochips Sales, by Country Million Units (2015-2020)
  • Table 189. North America Biochips Sales, by Type Million Units (2015-2020)
  • Table 190. North America Biochips Sales, by Application Million Units (2015-2020)
  • Table 191. North America Biochips Sales, by End User Million Units (2015-2020)
  • Table 192. United States Biochips Sales, by Type Million Units (2015-2020)
  • Table 193. United States Biochips Sales, by Application Million Units (2015-2020)
  • Table 194. United States Biochips Sales, by End User Million Units (2015-2020)
  • Table 195. Canada Biochips Sales, by Type Million Units (2015-2020)
  • Table 196. Canada Biochips Sales, by Application Million Units (2015-2020)
  • Table 197. Canada Biochips Sales, by End User Million Units (2015-2020)
  • Table 198. Mexico Biochips Sales, by Type Million Units (2015-2020)
  • Table 199. Mexico Biochips Sales, by Application Million Units (2015-2020)
  • Table 200. Mexico Biochips Sales, by End User Million Units (2015-2020)
  • Table 201. Biochips: by Type(USD/Units)
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Biochips: by Type(USD Million)
  • Table 213. Biochips DNA Chips , by Region USD Million (2021-2026)
  • Table 214. Biochips Protein Chips , by Region USD Million (2021-2026)
  • Table 215. Biochips Lab-on-a-Chip , by Region USD Million (2021-2026)
  • Table 216. Biochips Others , by Region USD Million (2021-2026)
  • Table 217. Biochips: by Application(USD Million)
  • Table 218. Biochips Drug Discovery & Development , by Region USD Million (2021-2026)
  • Table 219. Biochips Disease Diagnostics , by Region USD Million (2021-2026)
  • Table 220. Biochips Genomics , by Region USD Million (2021-2026)
  • Table 221. Biochips Proteomics , by Region USD Million (2021-2026)
  • Table 222. Biochips Agriculture , by Region USD Million (2021-2026)
  • Table 223. Biochips Others , by Region USD Million (2021-2026)
  • Table 224. Biochips: by End User(USD Million)
  • Table 225. Biochips Biotechnology & Pharmaceutical Companies , by Region USD Million (2021-2026)
  • Table 226. Biochips Hospitals & Diagnostics Centers , by Region USD Million (2021-2026)
  • Table 227. Biochips Academic & Research Institutes , by Region USD Million (2021-2026)
  • Table 228. Biochips Others , by Region USD Million (2021-2026)
  • Table 229. South America Biochips, by Country USD Million (2021-2026)
  • Table 230. South America Biochips, by Type USD Million (2021-2026)
  • Table 231. South America Biochips, by Application USD Million (2021-2026)
  • Table 232. South America Biochips, by End User USD Million (2021-2026)
  • Table 233. Brazil Biochips, by Type USD Million (2021-2026)
  • Table 234. Brazil Biochips, by Application USD Million (2021-2026)
  • Table 235. Brazil Biochips, by End User USD Million (2021-2026)
  • Table 236. Argentina Biochips, by Type USD Million (2021-2026)
  • Table 237. Argentina Biochips, by Application USD Million (2021-2026)
  • Table 238. Argentina Biochips, by End User USD Million (2021-2026)
  • Table 239. Rest of South America Biochips, by Type USD Million (2021-2026)
  • Table 240. Rest of South America Biochips, by Application USD Million (2021-2026)
  • Table 241. Rest of South America Biochips, by End User USD Million (2021-2026)
  • Table 242. Asia Pacific Biochips, by Country USD Million (2021-2026)
  • Table 243. Asia Pacific Biochips, by Type USD Million (2021-2026)
  • Table 244. Asia Pacific Biochips, by Application USD Million (2021-2026)
  • Table 245. Asia Pacific Biochips, by End User USD Million (2021-2026)
  • Table 246. China Biochips, by Type USD Million (2021-2026)
  • Table 247. China Biochips, by Application USD Million (2021-2026)
  • Table 248. China Biochips, by End User USD Million (2021-2026)
  • Table 249. Japan Biochips, by Type USD Million (2021-2026)
  • Table 250. Japan Biochips, by Application USD Million (2021-2026)
  • Table 251. Japan Biochips, by End User USD Million (2021-2026)
  • Table 252. India Biochips, by Type USD Million (2021-2026)
  • Table 253. India Biochips, by Application USD Million (2021-2026)
  • Table 254. India Biochips, by End User USD Million (2021-2026)
  • Table 255. South Korea Biochips, by Type USD Million (2021-2026)
  • Table 256. South Korea Biochips, by Application USD Million (2021-2026)
  • Table 257. South Korea Biochips, by End User USD Million (2021-2026)
  • Table 258. Taiwan Biochips, by Type USD Million (2021-2026)
  • Table 259. Taiwan Biochips, by Application USD Million (2021-2026)
  • Table 260. Taiwan Biochips, by End User USD Million (2021-2026)
  • Table 261. Australia Biochips, by Type USD Million (2021-2026)
  • Table 262. Australia Biochips, by Application USD Million (2021-2026)
  • Table 263. Australia Biochips, by End User USD Million (2021-2026)
  • Table 264. Rest of Asia-Pacific Biochips, by Type USD Million (2021-2026)
  • Table 265. Rest of Asia-Pacific Biochips, by Application USD Million (2021-2026)
  • Table 266. Rest of Asia-Pacific Biochips, by End User USD Million (2021-2026)
  • Table 267. Europe Biochips, by Country USD Million (2021-2026)
  • Table 268. Europe Biochips, by Type USD Million (2021-2026)
  • Table 269. Europe Biochips, by Application USD Million (2021-2026)
  • Table 270. Europe Biochips, by End User USD Million (2021-2026)
  • Table 271. Germany Biochips, by Type USD Million (2021-2026)
  • Table 272. Germany Biochips, by Application USD Million (2021-2026)
  • Table 273. Germany Biochips, by End User USD Million (2021-2026)
  • Table 274. France Biochips, by Type USD Million (2021-2026)
  • Table 275. France Biochips, by Application USD Million (2021-2026)
  • Table 276. France Biochips, by End User USD Million (2021-2026)
  • Table 277. Italy Biochips, by Type USD Million (2021-2026)
  • Table 278. Italy Biochips, by Application USD Million (2021-2026)
  • Table 279. Italy Biochips, by End User USD Million (2021-2026)
  • Table 280. United Kingdom Biochips, by Type USD Million (2021-2026)
  • Table 281. United Kingdom Biochips, by Application USD Million (2021-2026)
  • Table 282. United Kingdom Biochips, by End User USD Million (2021-2026)
  • Table 283. Netherlands Biochips, by Type USD Million (2021-2026)
  • Table 284. Netherlands Biochips, by Application USD Million (2021-2026)
  • Table 285. Netherlands Biochips, by End User USD Million (2021-2026)
  • Table 286. Rest of Europe Biochips, by Type USD Million (2021-2026)
  • Table 287. Rest of Europe Biochips, by Application USD Million (2021-2026)
  • Table 288. Rest of Europe Biochips, by End User USD Million (2021-2026)
  • Table 289. MEA Biochips, by Country USD Million (2021-2026)
  • Table 290. MEA Biochips, by Type USD Million (2021-2026)
  • Table 291. MEA Biochips, by Application USD Million (2021-2026)
  • Table 292. MEA Biochips, by End User USD Million (2021-2026)
  • Table 293. Middle East Biochips, by Type USD Million (2021-2026)
  • Table 294. Middle East Biochips, by Application USD Million (2021-2026)
  • Table 295. Middle East Biochips, by End User USD Million (2021-2026)
  • Table 296. Africa Biochips, by Type USD Million (2021-2026)
  • Table 297. Africa Biochips, by Application USD Million (2021-2026)
  • Table 298. Africa Biochips, by End User USD Million (2021-2026)
  • Table 299. North America Biochips, by Country USD Million (2021-2026)
  • Table 300. North America Biochips, by Type USD Million (2021-2026)
  • Table 301. North America Biochips, by Application USD Million (2021-2026)
  • Table 302. North America Biochips, by End User USD Million (2021-2026)
  • Table 303. United States Biochips, by Type USD Million (2021-2026)
  • Table 304. United States Biochips, by Application USD Million (2021-2026)
  • Table 305. United States Biochips, by End User USD Million (2021-2026)
  • Table 306. Canada Biochips, by Type USD Million (2021-2026)
  • Table 307. Canada Biochips, by Application USD Million (2021-2026)
  • Table 308. Canada Biochips, by End User USD Million (2021-2026)
  • Table 309. Mexico Biochips, by Type USD Million (2021-2026)
  • Table 310. Mexico Biochips, by Application USD Million (2021-2026)
  • Table 311. Mexico Biochips, by End User USD Million (2021-2026)
  • Table 312. Biochips Sales: by Type(Million Units)
  • Table 313. Biochips Sales DNA Chips , by Region Million Units (2021-2026)
  • Table 314. Biochips Sales Protein Chips , by Region Million Units (2021-2026)
  • Table 315. Biochips Sales Lab-on-a-Chip , by Region Million Units (2021-2026)
  • Table 316. Biochips Sales Others , by Region Million Units (2021-2026)
  • Table 317. Biochips Sales: by Application(Million Units)
  • Table 318. Biochips Sales Drug Discovery & Development , by Region Million Units (2021-2026)
  • Table 319. Biochips Sales Disease Diagnostics , by Region Million Units (2021-2026)
  • Table 320. Biochips Sales Genomics , by Region Million Units (2021-2026)
  • Table 321. Biochips Sales Proteomics , by Region Million Units (2021-2026)
  • Table 322. Biochips Sales Agriculture , by Region Million Units (2021-2026)
  • Table 323. Biochips Sales Others , by Region Million Units (2021-2026)
  • Table 324. Biochips Sales: by End User(Million Units)
  • Table 325. Biochips Sales Biotechnology & Pharmaceutical Companies , by Region Million Units (2021-2026)
  • Table 326. Biochips Sales Hospitals & Diagnostics Centers , by Region Million Units (2021-2026)
  • Table 327. Biochips Sales Academic & Research Institutes , by Region Million Units (2021-2026)
  • Table 328. Biochips Sales Others , by Region Million Units (2021-2026)
  • Table 329. South America Biochips Sales, by Country Million Units (2021-2026)
  • Table 330. South America Biochips Sales, by Type Million Units (2021-2026)
  • Table 331. South America Biochips Sales, by Application Million Units (2021-2026)
  • Table 332. South America Biochips Sales, by End User Million Units (2021-2026)
  • Table 333. Brazil Biochips Sales, by Type Million Units (2021-2026)
  • Table 334. Brazil Biochips Sales, by Application Million Units (2021-2026)
  • Table 335. Brazil Biochips Sales, by End User Million Units (2021-2026)
  • Table 336. Argentina Biochips Sales, by Type Million Units (2021-2026)
  • Table 337. Argentina Biochips Sales, by Application Million Units (2021-2026)
  • Table 338. Argentina Biochips Sales, by End User Million Units (2021-2026)
  • Table 339. Rest of South America Biochips Sales, by Type Million Units (2021-2026)
  • Table 340. Rest of South America Biochips Sales, by Application Million Units (2021-2026)
  • Table 341. Rest of South America Biochips Sales, by End User Million Units (2021-2026)
  • Table 342. Asia Pacific Biochips Sales, by Country Million Units (2021-2026)
  • Table 343. Asia Pacific Biochips Sales, by Type Million Units (2021-2026)
  • Table 344. Asia Pacific Biochips Sales, by Application Million Units (2021-2026)
  • Table 345. Asia Pacific Biochips Sales, by End User Million Units (2021-2026)
  • Table 346. China Biochips Sales, by Type Million Units (2021-2026)
  • Table 347. China Biochips Sales, by Application Million Units (2021-2026)
  • Table 348. China Biochips Sales, by End User Million Units (2021-2026)
  • Table 349. Japan Biochips Sales, by Type Million Units (2021-2026)
  • Table 350. Japan Biochips Sales, by Application Million Units (2021-2026)
  • Table 351. Japan Biochips Sales, by End User Million Units (2021-2026)
  • Table 352. India Biochips Sales, by Type Million Units (2021-2026)
  • Table 353. India Biochips Sales, by Application Million Units (2021-2026)
  • Table 354. India Biochips Sales, by End User Million Units (2021-2026)
  • Table 355. South Korea Biochips Sales, by Type Million Units (2021-2026)
  • Table 356. South Korea Biochips Sales, by Application Million Units (2021-2026)
  • Table 357. South Korea Biochips Sales, by End User Million Units (2021-2026)
  • Table 358. Taiwan Biochips Sales, by Type Million Units (2021-2026)
  • Table 359. Taiwan Biochips Sales, by Application Million Units (2021-2026)
  • Table 360. Taiwan Biochips Sales, by End User Million Units (2021-2026)
  • Table 361. Australia Biochips Sales, by Type Million Units (2021-2026)
  • Table 362. Australia Biochips Sales, by Application Million Units (2021-2026)
  • Table 363. Australia Biochips Sales, by End User Million Units (2021-2026)
  • Table 364. Rest of Asia-Pacific Biochips Sales, by Type Million Units (2021-2026)
  • Table 365. Rest of Asia-Pacific Biochips Sales, by Application Million Units (2021-2026)
  • Table 366. Rest of Asia-Pacific Biochips Sales, by End User Million Units (2021-2026)
  • Table 367. Europe Biochips Sales, by Country Million Units (2021-2026)
  • Table 368. Europe Biochips Sales, by Type Million Units (2021-2026)
  • Table 369. Europe Biochips Sales, by Application Million Units (2021-2026)
  • Table 370. Europe Biochips Sales, by End User Million Units (2021-2026)
  • Table 371. Germany Biochips Sales, by Type Million Units (2021-2026)
  • Table 372. Germany Biochips Sales, by Application Million Units (2021-2026)
  • Table 373. Germany Biochips Sales, by End User Million Units (2021-2026)
  • Table 374. France Biochips Sales, by Type Million Units (2021-2026)
  • Table 375. France Biochips Sales, by Application Million Units (2021-2026)
  • Table 376. France Biochips Sales, by End User Million Units (2021-2026)
  • Table 377. Italy Biochips Sales, by Type Million Units (2021-2026)
  • Table 378. Italy Biochips Sales, by Application Million Units (2021-2026)
  • Table 379. Italy Biochips Sales, by End User Million Units (2021-2026)
  • Table 380. United Kingdom Biochips Sales, by Type Million Units (2021-2026)
  • Table 381. United Kingdom Biochips Sales, by Application Million Units (2021-2026)
  • Table 382. United Kingdom Biochips Sales, by End User Million Units (2021-2026)
  • Table 383. Netherlands Biochips Sales, by Type Million Units (2021-2026)
  • Table 384. Netherlands Biochips Sales, by Application Million Units (2021-2026)
  • Table 385. Netherlands Biochips Sales, by End User Million Units (2021-2026)
  • Table 386. Rest of Europe Biochips Sales, by Type Million Units (2021-2026)
  • Table 387. Rest of Europe Biochips Sales, by Application Million Units (2021-2026)
  • Table 388. Rest of Europe Biochips Sales, by End User Million Units (2021-2026)
  • Table 389. MEA Biochips Sales, by Country Million Units (2021-2026)
  • Table 390. MEA Biochips Sales, by Type Million Units (2021-2026)
  • Table 391. MEA Biochips Sales, by Application Million Units (2021-2026)
  • Table 392. MEA Biochips Sales, by End User Million Units (2021-2026)
  • Table 393. Middle East Biochips Sales, by Type Million Units (2021-2026)
  • Table 394. Middle East Biochips Sales, by Application Million Units (2021-2026)
  • Table 395. Middle East Biochips Sales, by End User Million Units (2021-2026)
  • Table 396. Africa Biochips Sales, by Type Million Units (2021-2026)
  • Table 397. Africa Biochips Sales, by Application Million Units (2021-2026)
  • Table 398. Africa Biochips Sales, by End User Million Units (2021-2026)
  • Table 399. North America Biochips Sales, by Country Million Units (2021-2026)
  • Table 400. North America Biochips Sales, by Type Million Units (2021-2026)
  • Table 401. North America Biochips Sales, by Application Million Units (2021-2026)
  • Table 402. North America Biochips Sales, by End User Million Units (2021-2026)
  • Table 403. United States Biochips Sales, by Type Million Units (2021-2026)
  • Table 404. United States Biochips Sales, by Application Million Units (2021-2026)
  • Table 405. United States Biochips Sales, by End User Million Units (2021-2026)
  • Table 406. Canada Biochips Sales, by Type Million Units (2021-2026)
  • Table 407. Canada Biochips Sales, by Application Million Units (2021-2026)
  • Table 408. Canada Biochips Sales, by End User Million Units (2021-2026)
  • Table 409. Mexico Biochips Sales, by Type Million Units (2021-2026)
  • Table 410. Mexico Biochips Sales, by Application Million Units (2021-2026)
  • Table 411. Mexico Biochips Sales, by End User Million Units (2021-2026)
  • Table 412. Biochips: by Type(USD/Units)
  • Table 413. Research Programs/Design for This Report
  • Table 414. Key Data Information from Secondary Sources
  • Table 415. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biochips: by Type USD Million (2015-2020)
  • Figure 5. Global Biochips: by Application USD Million (2015-2020)
  • Figure 6. Global Biochips: by End User USD Million (2015-2020)
  • Figure 7. South America Biochips Share (%), by Country
  • Figure 8. Asia Pacific Biochips Share (%), by Country
  • Figure 9. Europe Biochips Share (%), by Country
  • Figure 10. MEA Biochips Share (%), by Country
  • Figure 11. North America Biochips Share (%), by Country
  • Figure 12. Global Biochips: by Type Million Units (2015-2020)
  • Figure 13. Global Biochips: by Application Million Units (2015-2020)
  • Figure 14. Global Biochips: by End User Million Units (2015-2020)
  • Figure 15. South America Biochips Share (%), by Country
  • Figure 16. Asia Pacific Biochips Share (%), by Country
  • Figure 17. Europe Biochips Share (%), by Country
  • Figure 18. MEA Biochips Share (%), by Country
  • Figure 19. North America Biochips Share (%), by Country
  • Figure 20. Global Biochips: by Type USD/Units (2015-2020)
  • Figure 21. Global Biochips share by Players 2020 (%)
  • Figure 22. Global Biochips share by Players (Top 3) 2020(%)
  • Figure 23. Global Biochips share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 26. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 27. Agilent Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Agilent Technologies Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Perkinelmer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Perkinelmer Inc. (United States) Revenue: by Geography 2020
  • Figure 31. Fluidigm Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Fluidigm Corporation (United States) Revenue: by Geography 2020
  • Figure 33. Illumina Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Illumina Inc. (United States) Revenue: by Geography 2020
  • Figure 35. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 36. GE Healthcare (United States) Revenue: by Geography 2020
  • Figure 37. Bio-Rad Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Bio-Rad Laboratories Inc. (United States) Revenue: by Geography 2020
  • Figure 39. Cepheid Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Cepheid Inc. (United States) Revenue: by Geography 2020
  • Figure 41. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2020
  • Figure 43. Roche Diagnostics AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 44. Roche Diagnostics AG (Switzerland) Revenue: by Geography 2020
  • Figure 45. Global Biochips: by Type USD Million (2021-2026)
  • Figure 46. Global Biochips: by Application USD Million (2021-2026)
  • Figure 47. Global Biochips: by End User USD Million (2021-2026)
  • Figure 48. South America Biochips Share (%), by Country
  • Figure 49. Asia Pacific Biochips Share (%), by Country
  • Figure 50. Europe Biochips Share (%), by Country
  • Figure 51. MEA Biochips Share (%), by Country
  • Figure 52. North America Biochips Share (%), by Country
  • Figure 53. Global Biochips: by Type Million Units (2021-2026)
  • Figure 54. Global Biochips: by Application Million Units (2021-2026)
  • Figure 55. Global Biochips: by End User Million Units (2021-2026)
  • Figure 56. South America Biochips Share (%), by Country
  • Figure 57. Asia Pacific Biochips Share (%), by Country
  • Figure 58. Europe Biochips Share (%), by Country
  • Figure 59. MEA Biochips Share (%), by Country
  • Figure 60. North America Biochips Share (%), by Country
  • Figure 61. Global Biochips: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Agilent Technologies Inc. (United States)
  • Perkinelmer Inc. (United States)
  • Fluidigm Corporation (United States)
  • Illumina Inc. (United States)
  • GE Healthcare (United States)
  • Bio-Rad Laboratories Inc. (United States)
  • Cepheid Inc. (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • Roche Diagnostics AG (Switzerland)
Additional players considered in the study are as follows:
Greiner Bio-One GmbH (Germany) , Zerzog GmbH & Co. KG Kunststofftechnik Recycling (Germany) , Otto Michael GmbH & Co. KG (Germany) , Astra Bitech GmbH (Germany)
Select User Access Type

Key Highlights of Report


Mar 2021 237 Pages 67 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global and Regional Biochips Quantitative research analysis
Global and Regional Biochips Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global and Regional Biochips Report?

Have a Query? Click Here

Other Related Reports

Phycocyanin Comprehensive Study by Application (Natural colourant, Pharmaceuticals), Nature (Organic, Conventional), Form (Powder, Liquid) Players and Region - Global Market Outlook to 2027
$ 3500
Cell Proliferation Kit Comprehensive Study by Type (Colorimetric Detection Method, Fluorescent Detection Method, Other), Application (Clinical, Industrial & Applied Science, Stem Cell Research), Cell...
$ 3350
Marine Biotechnology Comprehensive Study by Type (Marine Animal Technolog, Marine Plant Technology), Application (Cosmetics, Pharmaceuticals, Fine Chemical, Nutritional Supplements), Source (Algae, A...
$ 3450
Rat Model Comprehensive Study by Type (Inbred, Outbred, Knockout, Hybrid, Others), Application (Research and Development (Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, ...
$ 3650
Biomarker Comprehensive Study by Type (Safety Biomarkers, Efficacy Biomarkers (Predictive Biomarkers, Prognostic Biomarkers, Pharmacodynamic Biomarkers, Surrogate Biomarkers), Validation Biomarkers),...
$ 3750
Oral Proteins and Peptides Comprehensive Study by Type (Linaclotide, Plecanatide, Calcitonin, Insulin, Octreotide), Application (Gastric & Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disor...
$ 3650